Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study

Intensive Care Med. 2008 May;34(5):977-9. doi: 10.1007/s00134-008-0997-8. Epub 2008 Jan 23.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / therapeutic use*
  • Female
  • France / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Patient Selection
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Sepsis / drug therapy*
  • Sepsis / mortality
  • Survival Analysis

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated